Precipio’s Pathology Division exceeded monthly breakeven revenue goal in August

Precipio announces its Pathology Division has in August exceeded the monthly breakeven revenue goal which, if continued, causes this division to contribute cash to the Company’s operations. “As a sales executive, nothing is more exciting than seeing my team exceed their goals. We are on a track to contribute significantly to the Company’s revenues and financial performance,” said Bill Breit, VP of Pathology Sales. “This is, however, more than an increase in revenue. It tells me that Precipio’s team and technology are impacting more patient lives by reducing the misdiagnosis of hematologic malignancies.”